Viewing Study NCT00466960


Ignite Creation Date: 2025-12-25 @ 2:09 AM
Ignite Modification Date: 2026-01-07 @ 5:56 PM
Study NCT ID: NCT00466960
Status: COMPLETED
Last Update Posted: 2017-08-28
First Post: 2007-04-25
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy
Sponsor: University of Washington
Organization: